General Information of the Compound
| Compound ID |
CP0514128
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
ADX48621
Show/Hide
|
||||||||||||||||||
| Synonyms |
3590AH
6-Fluoro-2-(4-(pyridin-2-yl)but-3-yn-1-yl)imidazo(1,2-a)pyridine
6-fluoro-2-[4-(2-pyridinyl)-3-butyn-1-yl]-Imidazo[1,2-a]pyridine
872363-17-2
ADX 48621;ADX48621;ADX-48621
ADX-48621
ADX48621
AKOS030526956
BCP23706
BDBM50431705
C16H12FN3
CHEMBL2346738
CS-0690
CV8JZR21A1
DB-076892
DB12733
DTXSID90236230
Dipraglurant
Dipraglurant [INN]
FT-0705373
GTPL6452
HY-14859
J3.560.334D
NCGC00351745-02
SB16993
SCHEMBL103033
UNII-CV8JZR21A1
W-5761
ZINC72266314
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H12FN3
|
||||||||||||||||||
| Molecular Weight |
265.291
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H12FN3/c17-13-8-9-16-19-15(12-20(16)11-13)7-2-1-5-14-6-3-4-10-18-14/h3-4,6,8-12H,2,7H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
LZXMUJCJAWVHPZ-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
872363-17-2
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound